NeoPharm and Pharmacia & Upjohn reach licensing agreement for liposomal cancer formulations Feb. 24, 1999 No Comments
Activity of novel deoxyadenosine analogue investigated against human colon tumors Feb. 23, 1999 No Comments
FDA permits initiation of GlycoDesign's phase I/II study of GD0039 as chemoprotective agent Feb. 22, 1999 No Comments
Licensing partner sought for development of prohibitin gene-based cancer Rx, Dx Feb. 22, 1999 No Comments
Protein farnesyltransferase inhibitors in development at Bristol-Myers Squibb Feb. 19, 1999 No Comments
Genzyme's oncology division in-licenses angiogenesis inhibitor for development Feb. 19, 1999 No Comments
RSS